General Information of Drug Transporter (DT)
DT ID DTD0366 Transporter Info
Gene Name SLC44A4
Transporter Name Choline transporter-like protein 4
Gene ID
80736
UniProt ID
Q53GD3
Post-Translational Modification of This DT
Overview of SLC44A4 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-N-glycosylation X-Oxidation X-Phosphorylation X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC44A4 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

575

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC44A4 Lysine 575 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Affecting the conformation of the SLC44A4 and/or its interaction with its ligand [2]

Role of PTM

Conformational Change

Affected Drug/Substrate

Thiamine pyrophosphate

Results for Drug

Affecting uptake of thiamine pyrophosphate

Modified Residue

Asparagine

Modified Location

69

Experimental Material(s)

Retinal pigment epithelia (ARPE19) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Glycosylation at SLC44A4 Asparagine 69 have been reported to affect its conformation and/or interaction with its ligand.

  PTM Phenomenon 2

Affecting the conformation of the SLC44A4 and/or its interaction with its ligand [2]

Role of PTM

Conformational Change

Affected Drug/Substrate

Thiamine pyrophosphate

Results for Drug

Affecting uptake of thiamine pyrophosphate

Modified Residue

Asparagine

Modified Location

155

Experimental Material(s)

Retinal pigment epithelia (ARPE19) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Glycosylation at SLC44A4 Asparagine 155 have been reported to affect its conformation and/or interaction with its ligand.

  PTM Phenomenon 3

Affecting the conformation of the SLC44A4 and/or its interaction with its ligand [2]

Role of PTM

Conformational Change

Affected Drug/Substrate

Thiamine pyrophosphate

Results for Drug

Affecting uptake of thiamine pyrophosphate

Modified Residue

Asparagine

Modified Location

393

Experimental Material(s)

Retinal pigment epithelia (ARPE19) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Glycosylation at SLC44A4 Asparagine 393 have been reported to affect its conformation and/or interaction with its ligand.

  PTM Phenomenon 4

Have the potential to influence SLC44A4 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

197

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC44A4 Asparagine 197 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC44A4 [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

298

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC44A4 Asparagine 298 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC44A4 [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

405

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC44A4 Asparagine 405 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC44A4 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

416

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC44A4 Asparagine 416 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC44A4 [4]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

547

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC44A4 Cystine 547 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC44A4 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

688

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC44A4 Serine 688 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC44A4 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

690

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC44A4 Serine 690 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC44A4 [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

126

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC44A4 Threonine 126 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC44A4 [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

142

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC44A4 Threonine 142 has the potential to affect its expression or activity.

  Tyrosine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC44A4 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

13

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC44A4 Tyrosine 13 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC44A4 [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

141

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC44A4 Tyrosine 141 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC44A4 [10]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

560

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC44A4 Tyrosine 560 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC44A4 [5] , [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

685

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC44A4 Tyrosine 685 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC44A4 [5] , [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

686

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC44A4 Tyrosine 686 has the potential to affect its expression or activity.
References
1 Propofol pharmacokinetics. Pediatr Crit Care Med. 2003 Jan;4(1):124-5.
2 The human colonic thiamine pyrophosphate transporter (hTPPT) is a glycoprotein and N-linked glycosylation is important for its function. Biochim Biophys Acta. 2016 Apr;1858(4):866-71.
3 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: CTL4_HUMAN)
4 Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
5 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
6 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
7 Phosphoproteomics study on the activated PKC-induced cell death. J Proteome Res. 2013 Oct 4;12(10):4280-301.
8 A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
9 Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One. 2011 Jan 6;6(1):e15640.
10 CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res. 2009 Mar 15;69(6):2663-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.